Julien Edeline - Publications

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Journal: Cancer treatment reviews

Published: May 04, 2026

Health-related quality of life in biliary tract cancer clinical trials. The current state and future directions.

Journal: ESMO gastrointestinal oncology

Published: March 05, 2026

Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.

Journal: The lancet. Gastroenterology & hepatology

Published: February 15, 2026

Effectiveness and safety of selective internal radiation therapy using yttrium-90 glass microspheres for hepatocellular carcinoma: real-world results from the multi-center prospective PROACTIF cohort of 989 patients.

Journal: EClinicalMedicine

Published: January 07, 2026

Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEO.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 06, 2026

Randomized, multicenter Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or gemcitabine in patients with resected ampullary adenocarcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 31, 2025

Difficulties in identifying a signal of activity in the adjuvant setting for biliary tract cancer.

Journal: The lancet. Gastroenterology & hepatology

Published: December 19, 2025

Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort).

Journal: JHEP reports : innovation in hepatology

Published: December 18, 2025

Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.

Journal: JHEP reports : innovation in hepatology

Published: December 16, 2025

Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 23, 2025

Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancer.

Journal: Clinics and research in hepatology and gastroenterology

Published: November 14, 2025

Impact of Child Pugh B Stage for the Treatment of Advanced HCC.

Journal: Journal of hepatocellular carcinoma

Published: November 06, 2025